Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KDventures ABKDEVF 26 Capex-to-Operating-Cash-Flow is 0.00 as of Jun. 2026. GuruFocus rates KDEVF with a GF Score™ of 26/100 and a GF Value™ of $0.55. The stock has 4 warning signs investors should review. Among 241 Biotechnology companies, KDventures AB ranks worse than 414937.34% on this metric.
Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.
KDventures AB (OTCPK:KDEVF) Capex-to-Operating-Cash-Flow Explanation
Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.
Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.
KDventures AB Capex-to-Operating-Cash-Flow Related Terms
KDventures AB Capex-to-Operating-Cash-Flow Historical Data
* Premium members only.
The historical data trend for KDventures AB's Capex-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KDEVF vs VRTX, REGN, MRNA: Capex-to-Operating-Cash-Flow Comparison
For the Biotechnology subindustry, KDventures AB's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KDventures AB Capex-to-Operating-Cash-Flow vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, KDventures AB's Capex-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where KDventures AB's Capex-to-Operating-Cash-Flow falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Capex-to-Operating-Cash-Flow of 0.00 mean?
KDventures AB (KDEVF) has a Capex-to-Operating-Cash-Flow of 0.00 as of Jun. 2026. Capex to Operating Cash Flow ratio assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. View historical data on KDventures AB and its competitors. According to the industry distribution chart, KDventures AB ranks #999999 out of 241 companies in the Biotechnology industry.
Is KDventures AB's Capex-to-Operating-Cash-Flow too high?
KDventures AB's current Capex-to-Operating-Cash-Flow is 0.00. Based on the distribution chart, KDventures AB ranks #999999 out of 241 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, KDventures AB has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does KDventures AB's Capex-to-Operating-Cash-Flow compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, KDventures AB ranks #999999 out of 241 companies for Capex-to-Operating-Cash-Flow. This places KDventures AB in the lower half of its industry. The industry median Capex-to-Operating-Cash-Flow is 0.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Operating-Cash-Flow for a Biotechnology company?
The median Capex-to-Operating-Cash-Flow among Biotechnology companies is 0.35, based on 241 companies in the industry. Companies in the top quartile (top 25%) have a Capex-to-Operating-Cash-Flow significantly above this median, while those in the bottom quartile fall well below. However, Capex-to-Operating-Cash-Flow should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Operating-Cash-Flow mean?
A high Capex-to-Operating-Cash-Flow can signal that a stock is expensive relative to its fundamentals. Capex to Operating Cash Flow ratio assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. View historical data on KDventures AB and its competitors. For the Biotechnology industry, the median Capex-to-Operating-Cash-Flow is 0.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KDventures AB's current Capex-to-Operating-Cash-Flow is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDventures AB stock overvalued right now?
KDventures AB (KDEVF) has a current Capex-to-Operating-Cash-Flow of 0.00. The stock's GF Value™ is $0.55, compared to a current price of $0.26 — trading 53.2% below its estimated fair value. The current Capex-to-Operating-Cash-Flow is 0.00. KDventures AB's overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Operating-Cash-Flow calculated?
Capex-to-Operating-Cash-Flow is calculated from a company's financial statements. For KDventures AB (KDEVF), the current Capex-to-Operating-Cash-Flow is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KDventures AB (KDEVF) Overvalued in 2026?
Based on GuruFocus' analysis, KDventures AB stock appears to be undervalued.
The current stock price of $0.26 is trading 53.2% below its estimated GF Value™ of $0.55.
Key valuation signals for KDEVF:
Capex-to-Operating-Cash-Flow: 0.00
GF Value™: $0.55 vs. price of $0.26 (53.2% below fair value)
No single metric tells the full story. See the KDEVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KDventures AB is a Nordic investment company specialized in life sciences. The company identifies and invests in pharmaceutical projects and medical technology products originating from research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, the company creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with value growth potential.
26GF Score
Get the complete analysis for KDEVF
Capex-to-Operating-Cash-Flow is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KDEVF has been successfully added to your 
